Dr. Andrew C. Chang is a renowned thoracic surgeon specializing in esophageal and thoracic oncology. He serves as the Cameron Haight Collegiate Professor of Thoracic Surgery at the University of Michigan. Dr. Chang earned his undergraduate degree from the Massachusetts Institute of Technology and his medical degree from The Johns Hopkins University. He completed his general surgery residency at Vanderbilt University, where he was awarded an individual National Research Service Award from the National Institutes of Health to study cardiothoracic transplantation. He then pursued a thoracic surgery residency and fellowship at the University of Michigan, joining the faculty in 2003.
His clinical expertise focuses on the surgical management of esophageal cancer, incorporating minimally invasive techniques, complex open surgeries, and multimodal therapies to optimize patient outcomes. Dr. Chang’s research centers on thoracic oncology, with a particular emphasis on the tumorigenesis of esophageal cancer and its impact on surgical outcomes. His work investigates the progression from dysplasia in Barrett’s esophagus to esophageal adenocarcinoma, utilizing advanced molecular techniques such as microarray analysis and validation strategies to identify potential therapeutic targets and chemoprevention strategies.
Through his combined efforts in clinical practice and translational research, Dr. Chang is dedicated to advancing the understanding, treatment, and outcomes of esophageal cancer.
